Flag

OUR Facilities

Athens, Greece

With more than 3,000 sqm of R&D facilities, our team in Athens specialises in the development of Value Added Medicines and has been recently upgraded with HPAPI capabilities.

Gallery image
Gallery image
Gallery image
Gallery image
Gallery image
Gallery image
Gallery image
Gallery image
Gallery image

Our Site

Adragos Athens (formerly Lamda Laboratories) is a Contract Development site that focuses on providing quality research services for both generic and speciality pharmaceutical companies. We specialise in Generics, Value Added Medicines (VAMs) and New Chemical Entities (NCE) developments. We have a highly experienced team of more than 60 scientists that have worked on numerous innovative products. Our licensing spectrum encompasses approvals from the Hellenic Republic Ministry of Health. This authorizes the site to handle products such as clonazepam, phenobarbital, and fentanyl, as well as related compounds classified under the umbrella of narcotics, all for the purpose of developmental endeavours. 

We offer tailor-made services that cover a wide range of industry needs. From out-licensing and supply to one-off analysis, custom developments and advanced formulation services. Adragos Athens is able to cater to a multitude of customers with a diverse range of development requirements. 


Formulation and Process Development

Our Formulation and Process Development activities are conducted in a GMP-like environment, mimicking the layout of a full-scale manufacturing site. Equipped with small-scale R&D equipment boasting a wide range of capabilities and techniques, we ensure seamless scale-up to different manufacturing sites.

EU GMP and FDA

Our GMP analytical laboratory is at the forefront of technology, equipped to handle the analytical challenges posed by both generic and complex developments. It holds EU GMP approval and is prepared for FDA inspection.

Additionally, our facility houses Stability Chambers and Walk-In rooms to preserve samples for all stability testing conducted at Adragos Athens.

Quality by Design

Quality by Design (QbD) is incorporated into every development. By ensuring QbD touches each point of the commercial manufacturing process we are able to develop consistent, quality pharmaceutical products. 

Collaborative Excellence in Manufacturing

We not only collaborate with the Adragos production network, but also with an established network of third party CMOs, to ensure that all clinical and commercial manufacturing needs are met across all technologies with the same high standards of quality and efficiency following the product development phase.  

Our Services

We specialise in Generics, Value Added Medicines (VAMs) and New Chemical Entities (NCE) developments. We have a highly experienced team of more than 60 scientists that have worked on numerous innovative products. 

Formulation Development
  • API characterization
  • Preformulation
  • Formulation development
  • Analytical method development
  • Process development
  • Technology transfer
  • IP Search
Analytical Services
  • Method development and validation
  • Chemical compatibility
  • Forced degradation
  • Dissolution (USP I, II and III)
  • Chemical analysis of APIs
  • Finished product controls
  • ICH stability, photostability and in-use stability
Scientific and Clinical Development
  • Clinical strategy
  • Study design and sample size calculation
  • BCS Biowaivers
  • Dissolution data analysis
  • IVIVC
  • Clinical trial project management
  • Nonclinical and clinical overviews
  • Scientific advice meetings
Supply Chain & Project Management
  • API and CMO selection & qualification 
  • Raw material sourcing 
  • Project management for new product developments & transfer 
  • Coordination of registration batches (Planning & Procurement) 
  • Commercial production planning 
  • Finished product supply  
  • Launch preparation for new SKUs 
  • Inventory management and optimization 
Regulatory Services
  • Regulatory and registration strategy
  • Scientific report writing
  • Compilation and publishing of data in eCTD format
  • Liaising with regulatory authorities
  • Registration services and support
  • Risk assessment reports
Certifications and Quality Processes
  • EU-GMP 
  • Compliance with FDA regulations, achieved through comprehensive FDA readiness initiatives.  
  • HPAPI Capabilities  

Key Information

Location: Athens, Greece
SQM: 3,000 m²
Foundation Year: 2014
FTE (Employees): 70

Certifications

Certified under EU-GMP standards 
Compliance with FDA regulations, achieved through comprehensive FDA readiness initiatives. 

Expertise

• Formulation development
• Analytical services
• Scientific and clinical development
• Regulatory services
• Supply chain and planning
• Expertise in Value Added Medicines, Generics and Generic Plus.
• Experience with over 150 molecules
• HPAPI and controlled substances capabilities 

Person

Aggelos Karatzas

Aggelos is the Head of Adragos Athens, where he skillfully leads the team to expand capabilities and
drive new product developments. With over fifteen years of experience in R&D operations and seven years in his
current position, Aggelos has played a pivotal role in the company’s success.

For a more comprehensive look into Aggelos’s professional profile, connect with him on LinkedIn.

Subscribe to our newsletter!

Get notified on our latest news.